Samantha Ruth Prabhu is currently busy promoting Kushi opposite Vijay Deverakonda.
Reportedly, Samantha Ruth Prabhu will have to face huge losses as she is rumored to be taking a break from acting in view of her health issues.
Samantha Ruth Prabhu fans were in for a big shock when several media reports claimed that the actress is going on an acting break for a year due to her health issues. samantha Currently battling with an auto-immune disease called Myositis. He shared the news of his diagnosis in October 2022.
Samantha has apparently decided not to sign any Telugu, Tamil or Bollywood film after completing Citadel India and Kushi and has even returned the advance payment to the makers. As a result, according to GreatAndhra.com, the actress would “lose a huge amount of money during this period”.
The report states: “Considering that Samantha usually charges between Rs 3.5 to 4 crore per film, and considering that she has recently signed three projects, her potential loss is between Rs 10 to 12 crore.”
Samantha recently confirmed her break in a social media post, announcing the closure of Citadel India. He wrote: “And that’s the end of Citadel India. Breaks don’t seem like a bad thing at all when you know what’s going to happen @rajanddk @mensit the family I didn’t know I needed for helping me fight every fight and never leaving my side Thank you for… I want more than anything in the world to make you proud… Thank you for the role of a lifetime… That is until you write me next.’
While Kushi is scheduled to release in September, Citadel India is yet to announce the release date. In Kushi, Samantha stars opposite Vijay Deverakonda while she teams up with Varun Dhawan for the series Raj and DK.
